AI vs Bureaucracy: Reinventing National Security Compliance from the Ground Up | Andrew Black - CEO, Kovr.ai

Episode notes

Send us Fan Mail Most people assume national security delays are about technology. They’re not. They’re about paperwork - and it can take up to two years just to deploy software the government already wants. Andrew Black is a national security entrepreneur, cybersecurity executive, and emerging technology strategist whose career has sat at the intersection of AI, defense, cyber risk, and global security operations. Andrew is currently the CEO of Kovr.ai ( ) an AI-native cyber compliance platform focused on one of the biggest bottlenecks in modern national security: getting software and cloud systems authorized for use in highly regulated and classified environments. Kovr.ai is using AI to automate complex compliance frameworks like FedRAMP and CMMC, helping organizations become “ATO-ready” (Authority to Operate) in minutes rather than months.

Related episodes across the Index

Other episodes covering the same guests and topics, from across The B2B Podcast Index.

• Why Most Startups Fail: Founders Don’t Know What They Don’t Know YetBuilt Not Born: The Startup Go-To-Market Podcast · on Cybersecurity80 / 100
• Ep. 85 - Building a first check partnershipCrossing the Valley · on Defense tech77 / 100
• Episode 46 - from Tashkent to Termsheet with Victor OrlovskyThe GoingVC Podcast · on Cybersecurity77 / 100
• The Right Amount of Awesome - PunchAn Agency Story · on Defense tech76 / 100
• Reframing Marketing ROI to Return on Objectives with Karl Van den BerghThe B2B CMO Podcast with Jon Miller and Sydney Sloan · on Cybersecurity75 / 100
• The Growth Engine - Series 2 Episode 7: How Seraphim Raised £137M by Marketing Space Investing to Retail Investors | Leah MartinThe Growth-Engine Marketing Podcast · on national security72 / 100

• Building the Internet of Medicine: How AI Could Transform Children's Healthcare | Dr. Timothy Chou - Founder, Pediatric Moonshot92 / 100
• The Blood Test That Could Change Cancer Treatment Forever | Eric Matthews - General Manager, Biopharma, Natera65 / 100
• How Female Biology Shapes Skin Disease Across a Lifetime | Dr. Doral Fredericks, PharmD, MBA - Vice President and Head of Global Medical Affairs and Outcomes Research, Organon56 / 100
• 55 Years Without a Diagnosis | Can AI Solve The Undiagnosed Condition Blind Spot? | Haresh Patel - Founder and CEO, Sanare Health AI70 / 100
• How Regenerative Medicine Is Reinventing Breast Reconstruction | Dr. Claudia Chavez-Munoz, MD, PhD - Chief Scientific Officer and Co-Founder - Conexeu Sciences